Trials / Completed
CompletedNCT00961532
Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The investigators intend to show that DDAVP improves platelet activity from baseline to 60 minutes after treatment start.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DDAVP injection (desmopressin acetate) | 0.4 mcg/kg in 250 mL NS intravenously once over 30 minutes |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2009-08-19
- Last updated
- 2014-08-28
- Results posted
- 2014-08-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00961532. Inclusion in this directory is not an endorsement.